Spire Wealth Management Atossa Therapeutics, Inc. Transaction History

Spire Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$0.85 - $1.28 $5,355 - $8,064	6,300 Added 6.7%	100,300 $109,000
Q1 2022 Apr 18, 2022	BUY	$1.11 - $1.74 $42,180 - $66,120	38,000 Added 67.86%	94,000 $118,000
Q4 2021 Jan 14, 2022	SELL	$1.6 - $3.27 $8,000 - $16,350	-5,000 Reduced 8.2%	56,000 $90,000
Q3 2021 Oct 22, 2021	BUY	$2.89 - $6.4 $37,570 - $83,200	13,000 Added 27.08%	61,000 $199,000
Q2 2021 Jul 26, 2021	BUY	$1.52 - $8.62 $4,560 - $25,859	3,000 Added 6.67%	48,000 $335,000
Q1 2021 May 21, 2021	BUY	$0.92 - $4.33 $41,400 - $194,850	45,000 New	45,000 $95,000

26.5M

466K

91.8K

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $130M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.